GTS Securities LLC purchased a new position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 75,048 shares of the company's stock, valued at approximately